How have RZLTD shares performed in 2024?

Rezolute's stock was trading at $0.9925 on January 1st, 2024. Since then, RZLTD stock has increased by 232.5% and is now trading at $3.30. View the best growth stocks for 2024 here .

How do I buy shares of Rezolute?

Shares of RZLTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:RZLTD

Rezolute (RZLTD) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free RZLTD Stock Alerts

$3.30

+0.06 (+1.85%)

(As of 04/18/2024 ET)

Compare

Today's Range: $3.24
▼
$3.49
50-Day Range: $1.00
▼
$3.24
52-Week Range: $16.00
▼
$24.05

Volume: 282,184 shs
Average Volume: 4,788 shs
Market Capitalization: $27.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart

Get Rezolute alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Rezolute

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also develops RZ402, a small molecule plasma kallikrein inhibitor, which is in preclinical stage for the treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

RZLTD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RZLTD Stock News Headlines

November 9, 2023 | investing.com

Rezolute (RZLT) Earnings Dates & Reports

September 3, 2023 | investing.com

Xilio Development Inc (XLO)

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

August 9, 2023 | forbes.com

Systems Ltd.

June 1, 2023 | benzinga.com

Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease

May 15, 2023 | markets.businessinsider.com

Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Jazz Pharmaceuticals (JAZZ)

May 12, 2023 | finanznachrichten.de

Rezolute, Inc.: Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress

May 11, 2023 | finance.yahoo.com

Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 25, 2023 | finance.yahoo.com

Great news for Rezolute, Inc. (NASDAQ:RZLT): Insiders acquired stock in large numbers last year

March 28, 2023 | markets.businessinsider.com

Rezolute (RZLT) Gets a Buy from H.C. Wainwright

February 12, 2023 | finanznachrichten.de

Rezolute, Inc.: Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress

February 10, 2023 | finance.yahoo.com

Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress

February 7, 2023 | benzinga.com

Xeris Biopharma Holdings Stock (NASDAQ:XERS), Quotes and News Summary

February 2, 2023 | finance.yahoo.com

After losing 37% in the past year, Rezolute, Inc. (NASDAQ:RZLT) institutional owners must be relieved by the recent gain

November 10, 2022 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Rezolute (RZLT)

November 1, 2022 | technews.tmcnet.com

Rezolute to Present at the Jefferies London Healthcare Conference

See More Headlines

Receive RZLTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rezolute and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:RZLTD
CUSIP: N/A
CIK: N/A
Web: www.rezolutebio.com
Phone: 650 206 4507
Fax: N/A
Employees: 23
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-20,330,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -153.46%
Return on Assets: -111.71%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.26
Quick Ratio: 3.26

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.24 per share
Price / Book: 2.66

Miscellaneous

Outstanding Shares: 8,418,000
Free Float: N/A
Market Cap: $27.78 million
Optionable: Not Optionable
Beta: 4.63

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Nevan Charles Elam (Age 53)
CEO & Director
Comp: $869.45k
Dr. Keith A. Vendola M.B.A. (Age 48)
M.D., MBA, Chief Financial Officer
Comp: $422.76k
Dr. Sankaram Mantripragada (Age 60)
Chief Scientific Officer
Comp: $620.76k
Mr. Michael R. Deperro
Head of Operations
Dr. Brian Roberts
Head of Clinical Devel.
Ms. Paula Opal
Head of Regulatory
Dr. Sharon Xueyan Wang
Head of Preclinical Devel.

Key Competitors

View All Competitors

RZLTD Stock Analysis - Frequently Asked Questions

How have RZLTD shares performed in 2024?: Rezolute's stock was trading at $0.9925 on January 1st, 2024. Since then, RZLTD stock has increased by 232.5% and is now trading at $3.30.
View the best growth stocks for 2024 here.
How do I buy shares of Rezolute?: Shares of RZLTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RZLTD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rezolute (RZLTD) Stock Price, News & Analysis

About Rezolute

RZLTD Stock Price History

RZLTD Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

RZLTD Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info